Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-07

Clinical Trial Update: Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating intermittent fasting with a fasting-mimicking diet to improve prostate cancer control and metabolic outcomes is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Stephen Freedland | Conditions: Prostate Adenocarcinoma | Phase 2 | Status: RECRUITING